Zobrazeno 1 - 10
of 248
pro vyhledávání: '"Turoctocog alfa"'
Publikováno v:
Bleeding, Thrombosis and Vascular Biology, Vol 3, Iss 1 (2024)
Although the use of prophylaxis regimens with prolonged half-life factors is now widespread in the world of hemophilia A, there is a lack of real-life evidence on the impact of these products on joint health, adherence, and quality of life of patient
Externí odkaz:
https://doaj.org/article/642f684552ae4a348e003b6ca66d2792
Publikováno v:
Patient Preference and Adherence, Vol Volume 17, Pp 3001-3014 (2023)
Hermann Eichler,1 Azusa Nagao,2 John Waller,3 Alexander Stuber4 1Institute of Clinical Hemostaseology and Transfusion Medicine, Saarland University, Homburg, Germany; 2Department of Blood Coagulation, Ogikubo Hospital, Tokyo, Japan; 3Novo Nordisk, Zu
Externí odkaz:
https://doaj.org/article/ee3631764a384ad1a0e601a5b5831a3c
Publikováno v:
Journal of Blood Medicine, Vol Volume 12, Pp 9-20 (2021)
Mariasanta Napolitano,1 Arne Agerlin Olsen,2 Anne Mette Nøhr,2 Hermann Eichler3 1Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo Reference Regional Center for Thrombos
Externí odkaz:
https://doaj.org/article/7f12c3cae932405f845e02cef8c21164
Autor:
Federica Demma, Pierpaola Arpa
Publikováno v:
AboutOpen, Vol 9, Iss 1 (2022)
Background: Hemophilia-A is an X-linked genetic disorder arising from a mutation to the X chromosome and causing either a quantitative or qualitative deficiency in blood clotting factor-VIII (FVIII). Several recombinant extended half-life FVIII produ
Externí odkaz:
https://doaj.org/article/810639f9709541bbb3ed78cabc926330
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol Volume 13, Pp 39-51 (2021)
Gary Benson,1 Tim Morton,2 Huw Thomas,3 Xin Ying Lee4 1Northern Ireland Haemophilia Comprehensive Care Centre and Thrombosis Unit, Belfast City Hospital, Belfast, UK; 2DRG, Bicester, UK; 3Biopharm, Novo Nordisk Ltd, Gatwick, UK; 4Biopharm Access, Nov
Externí odkaz:
https://doaj.org/article/1e33f88a5eea44048bb9c63d8865b386
Autor:
Wu R, Sun J, Xu W, Hu Q, Li W, Xiao J, Yang F, Zeng X, Zeng Y, Zhou J, Matytsina I, Zhang S, Pluta M, Yang R
Publikováno v:
Therapeutics and Clinical Risk Management, Vol Volume 16, Pp 567-578 (2020)
Runhui Wu,1 Jing Sun,2 Weiqun Xu,3 Qun Hu,4 Wenqian Li,5 Jianwen Xiao,6 Feng’e Yang,7 Xiaojing Zeng,8 Yun Zeng,9 Jianfeng Zhou,4 Irina Matytsina,10 Sali Zhang,11 Michael Pluta,12 Renchi Yang13 1Hematology Oncology Center, Beijing Children’s Hospi
Externí odkaz:
https://doaj.org/article/8f16c00516164c3a87a7fd931c2b8412
Autor:
Steven R. Lentz, Kaan Kavakli, Robert Klamroth, Mudi Misgav, Azusa Nagao, Alberto Tosetto, Pernille Juul Jørgensen, Marek Zak, Laszlo Nemes
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 2, Pp n/a-n/a (2022)
Abstract Background N8‐GP (turoctocog alfa pegol; Esperoct) is a glycoPEGylated human recombinant factor VIII (FVIII). Objectives Pathfinder8 (NCT01480180) was a phase 3, multinational, open‐label, nonrandomized trial to investigate the long‐te
Externí odkaz:
https://doaj.org/article/f97499a8365a4b5fbf4ba7b99c85a0bc
Publikováno v:
Patient Preference and Adherence, Vol Volume 13, Pp 497-513 (2019)
Susan Kearney,1,* Leslie J Raffini,2 Tan P Pham,3 Xin Ying Lee,4 Sylvia von Mackensen,5,* Andrea Landorph,6 Hideyuki Takedani,7 Johannes Oldenburg8 1Center for Bleeding and Clotting Disorders, Children’s Hospital Minnesota, Minneapolis, MN, USA; 2D
Externí odkaz:
https://doaj.org/article/34deab6a2ede4b82803e784137ac92ea
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Stability of Turoctocog Alfa, a Recombinant Factor VIII Product, during Continuous Infusion In Vitro
Publikováno v:
TH Open, Vol 04, Iss 04, Pp e354-e361 (2020)
Objective Turoctocog alfa is a recombinant factor VIII (rFVIII) for the prevention and treatment of bleeding in patients with hemophilia A, including those undergoing surgery and invasive medical procedures. This in vitro study evaluated the physical
Externí odkaz:
https://doaj.org/article/b55cdf46a02f48d4943831a11b19398e